Pharmaceutical Growth Hormone Overview
Genotropin Pen 36iu is a pharmaceutical-grade recombinant human growth hormone preparation manufactured using advanced biotechnology. This somatropin formulation contains 36 international units of bioidentical growth hormone engineered through recombinant DNA technology. Researchers at Stroid UK Shop examine this compound for its molecular structure and biological activity in laboratory settings, particularly investigating growth factor receptor binding mechanisms and downstream signalling cascades.
The pen delivery system provides precise measurement capabilities for controlled dosing in experimental protocols. Scientists study this pharmaceutical preparation to understand growth hormone receptor activation, IGF-1 pathway modulation, and cellular metabolism regulation. Research applications include investigating protein synthesis mechanisms, lipolytic pathways, and tissue regeneration processes in various cell culture models and controlled laboratory environments.
Research Applications in Laboratory Studies
Laboratory investigations with Genotropin examine growth hormone’s role in cellular proliferation, protein synthesis regulation, and metabolic pathway modulation. Researchers analyse how this recombinant somatropin influences gene expression patterns related to growth factor signalling, particularly IGF-1 production and anabolic cellular responses. Studies focus on understanding receptor binding affinity, signal transduction mechanisms, and downstream effects on cellular metabolism.
Scientists investigating growth hormone research compounds examine this preparation’s effects on lipolytic enzyme activation and carbohydrate metabolism regulation. Research protocols evaluate amino acid uptake mechanisms, nitrogen retention processes, and cellular energy expenditure pathways. Comparative studies with selective androgen receptor modulators and research peptides provide insights into different anabolic signalling pathways and their molecular mechanisms of action.
Technical Specifications
| Active Ingredient | Recombinant Human Growth Hormone (Somatropin) |
|---|---|
| Concentration | 36 International Units |
| Molecular Weight | 22,124 Daltons |
| Sequence Length | 191 Amino Acids |
| Storage Temperature | 2-8°C Refrigeration Required |
| Stability | Use within expiration date |
| Presentation | Pre-filled pen delivery system |
| Purity | Pharmaceutical grade |
Laboratory Compliance Statement
This Genotropin Pen 36iu preparation is supplied exclusively for in-vitro research applications and laboratory studies. The product is intended solely for qualified researchers conducting controlled investigations into growth hormone receptor mechanisms, cellular signalling pathways, and metabolic regulation studies. This compound is not approved for human consumption, therapeutic use, or any application outside accredited research facilities. Researchers must maintain appropriate biosafety protocols and institutional oversight when handling this pharmaceutical-grade material.
